Natera, Inc. (NTRA) vs Teva Pharmaceutical Industries Limited (TEVA)

A side-by-side comparison of Natera, Inc. and Teva Pharmaceutical Industries Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NTRA vs TEVA

growth of $100 · dividends reinvested · last 10y
NTRA +3613.4% (+43.5%/yr)TEVA -15.8% (-1.7%/yr)NTRA compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020182020202220242026$3,713$84
NTRA TEVA

NTRA vs TEVA: by the numbers

  • •NTRA is the larger company ($58.77B vs $46.04B market cap).
  • •TEVA is profitable (4.08% net margin) while NTRA runs a net loss (-7.11%).
  • •NTRA grew revenue faster over the past five years (39.92% vs 1.19% CAGR).

Metrics side by side

Valuation

MetricNTRATEVA
P/E ratioN/A65.88
Forward P/EN/A20.04
P/S ratio21.712.66
P/B ratio32.265.94
EV / EBITDAN/A19.94
FCF yield0.12%2.93%

Profitability

MetricNTRATEVA
Gross margin65.30%52.47%
Operating margin-10.70%11.45%
Net margin-7.11%4.08%
ROE-10.56%9.10%
ROIC-13.26%6.79%

Growth (annualized)

MetricNTRATEVA
Revenue CAGR (5Y)39.92%1.19%
Total return CAGR (5Y)29.45%32.30%

Frequently asked

Which has grown faster, NTRA or TEVA?
Over the past five years, NTRA grew revenue faster — NTRA at a 39.92% CAGR versus TEVA at 1.19%.
Is NTRA or TEVA more profitable?
TEVA runs the higher net margin — NTRA at -7.11% versus TEVA at 4.08%.
How have NTRA and TEVA total returns compared?
Over the past 10 years, NTRA delivered 43.39% and TEVA delivered -1.15% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.